No Detail Found!

Comparison of efficiency between Rosuvastatin and Atorvastatin in reducing low-density lipoprotein (LDL-C) in patients with diabetes mellitus

Author(s)
Saad Ahmed Khokhar Department of Medicine, Nishtar Medical University and Hospital,Multan,Pakistan
Rai Muhammad Farooq ur Rehman Department of Medicine, Nishtar Medical University and Hospital,Multan,Pakistan
Seemal Masood Department of Medicine, Nishtar Medical University and Hospital,Multan,Pakistan
Abstract
The study was designed to compare Rosuvastatin with Atorvastatin in terms of their efficacy to reduce low-density lipoproteins (LDL-C) in patients with type 2 diabetes mellitus. For this purpose, a cross-sectional analytical study was conducted in the OPD of Nishtar Medical Hospital, Multan, for six months. The study enrolled 66 patients who were consecutively allocated for double-blind therapy with 10mg Atorvastatin (n = 33) and 10mg Rosuvastatin (n = 33) for one month. The doses titration was carried up to four months in certain patients who failed to achieve 1998 European LDL-C level in the fi rst month. A signifi cant number of patients who were given 10mg Rosuvastatin matched the 1998 LDL-C goal in compared to the patients with 10mg dose of atorvastatin at one month (51% vs 46%, p< 0.0001) and at four months (94% vs 88%, p<0.05). Conclusively, Rosuvastatin was signifi cantly more efficacious than Atorvastatin in its ability to reduce LDL-C.
Publication Details
Page(s) 2288-2290
Published Journal: Journal of Pakistan Medical Association, Volume: 72, Issue: 11, Year: 2022

Request the full text from PASTIC

Keywords
T2DM, atorvastatin, LDL-C, Rosuvastatin, Statins
0

Citations

0

Downloads

96

Views